PROTOTYPE · batch IDs and test dates are sample data pending live lab COAs
← All Compounds
Metabolic

Tirzepatide

GLP-1 / GIP dual receptor agonist

A dual incretin receptor agonist peptide. Characterization pending current-batch analysis.

10mg$80
--
Verification Pending

This compound is not yet listed for sale. Under the AION standard it cannot appear as available until a current certificate is on file.

Characterization & Methods

Characterization

Incretin-Class Peptides: Identity & Characterization

Incretin-class research peptides are characterized by their receptor-binding sequences and molecular mass. AION verifies each batch against a reference standard by HPLC-UV and confirms identity by mass spectrometry before a batch is listed.

All compounds are sold strictly for laboratory research purposes. Not for human consumption, not for therapeutic, diagnostic, or any other use.